Floatz logo

EXEMESTANE

Anatomic Stage 0 Breast Cancer AJCC v8

Alliance for Clinical Trials in OncologySmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Anatomic Stage 0 Breast Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Letrozole
Alliance for Clinical Trials in Oncology
Phase 4BBB
TAMOXIFEN
Alliance for Clinical Trials in Oncology
Phase 4BB
Arimidex
Alliance for Clinical Trials in Oncology
Phase 4BB
Cyclophosphamide
Roswell Park Cancer Institute
Phase 3BB
TAMOXIFEN
Fred Hutchinson Cancer Center
Phase 4BB

View all 29 →

Same molecule, other indications

EXEMESTANE is also rated in:

estrogen-receptor positive breast cancerDormant
BBB
Indicative ·
75 / 100
View asset →
ER+ Breast CancerDormant
BBB
Indicative ·
75 / 100
View asset →
hormone receptor-positive breast cancerDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →